Espoo, Finland, 8 February 2021 – Medtentia International Ltd Oy (“Medtentia”), the cardiovascular device company developing new transformative solutions for mitral valve repair based on its groundbreaking helix technology platform, today announced that it has reached major milestones in its research and development work. Medtentia’s transcatheter mitral valve repair solution, CathHELIX®, has demonstrated excellent efficacy […]
Espoo, Finland, 4 December 2020 – Medtentia, the cardiovascular device company developing new transformative solutions for mitral valve repair, will present at the ICI for All Global Digital Summit, 6-7 December 2020. Clinical advisor to Medtentia, Kari Kervinen, MD, PhD, Oulu University Hospital, Finland, will present Physiological Downsizing of Mitral Annulus with Medtentia CathHELIX: Long […]
Espoo, Finland, 20 November 2020 – Medtentia, the cardiovascular device company developing new transformative solutions for mitral valve repair, announces that it will present at the PCR London Valves E-Course running from 22-24 November 2020. Kari Kervinen, MD, PhD, Oulu University Hospital, Finland, and clinical advisor to Medtentia, will present Treatment of MR: physiological annulus […]
Espoo, Finland, 11 November 2020 – Medtentia, the cardiovascular device company developing new transformative solutions for mitral valve repair, today announces that it will present at the Nordic-American Life Science Investment and Partnering virtual conference on 12 November 2020. Olli Keränen, CEO and Founder of Medtentia will present in the first session at 8.10am EST […]
Espoo, Finland, 6 December 2019 – Medtentia, the cardiovascular device company developing new transformative solutions for mitral valve repair, announces that data on its transcatheter mitral valve will be presented at the ICI Meeting in Tel Aviv, Israel, 8-10 December 2019. Clinical advisor to Medtentia, Kari Kervinen, MD, PhD, from Oulu University Hospital, Finland, will […]
Espoo, Finland, 25 September 2019 – Medtentia, the cardiovascular device company developing new transformative solutions for mitral valve repair, today announces that the Center for Devices and Radiological Health (CDRH) of the US Food and Drug Administration (FDA), has granted Breakthrough Device designation for its lead product, CathHELIX®. CathHELIX® is an investigational transcatheter mitral valve […]
Medtentia, the cardiovascular device company developing new transformative solutions for mitral valve repair, today announces that it will present at Transcatheter Cardiovascular Therapeutics, taking place at the Colorado Convention Center in Denver, Colorado, 29 October – 2 November. Clinical Adviser, Professor Bruno Scheller MD, will present CathHELIX: A Novel Transcatheter Mitral Valve Repair System as part […]
Medtentia, the cardiovascular device company developing new transformative solutions for mitral valve repair, today announces that it will present data at the 2017 PCR Innovators Day, taking place at ExCel London on 24 September. Clinical Advisor, Professor Bruno Scheller MD, will give a presentation entitled Transcatheter CathHELIX mitral valve repair, at 16.20 GMT. The PCR […]
Medtentia, the cardiovascular device company developing new transformative solutions for mitral valve repair, today announces that Medtentia Annuloplasty System initial study data will be presented as an e-poster at the Heart Valve Society Scientific Meeting 2017, taking place between 2-4 March at the Grimaldi Forum, Monaco. E-poster P137 Medtentia Annuloplasty System: Results of an Early […]
The statistical analysis of Medtentia’s proof-of-concept study evaluating the Medtentia Annuloplasty Ring (MAR) has recently been completed. As previously expected based on preliminary data analyses, the main safety- and performance- related objectives of the study were successfully achieved. The newly analyzed results indicate that the MAR ring is well tolerated and induces improvement of heart […]